Stock VINEETLAB VINEET LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Vineet Laboratories Limited

Equities

VINEETLAB

INE505Y01010

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 05:36:17 2024-05-29 am EDT 		5-day change 1st Jan Change
58.65 INR +4.73% Intraday chart for Vineet Laboratories Limited +14.19% -28.05%
Feb. 12 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Vineet Laboratories Limited Announces Appointment of Mr. Rameshkumar Bandari as Company Secretary and Compliance Officer CI

Business Summary

Vineet Laboratories Limited is engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. It also exports API intermediates, fine chemicals, and custom synthesis molecules.

Number of employees: 72

Sales per Business

INR in Million2021Weight2022Weight Delta
Drug Intermediates & Bulk Drugs
99.6 %
- - 1,903 99.6 % -
Job Work Receipts
0.3 %
2 0.1 % 6 0.3 % +207.64%
Scrap
0.1 %
- - 2 0.1 % -
Other
0.0 %
- - 0 0.0 % -

Sales per region

INR in Million2022Weight2023Weight Delta
India
100.0 %
1,912 100.0 % 2,123 100.0 % +11.05%

Managers

Managers TitleAgeSince
Satish Pandurang Samant CEO
 Chief Executive Officer - 23-10-15
Satyanarayana Raju Bhupathiraju DFI
 Director of Finance/CFO 74 16-11-09
Rameshkumar Bandari CMP
 Compliance Officer - Nov. 09
D. Veeta Venkat Rao CTO
 Chief Tech/Sci/R&D Officer - -
Venkata Ramana Gaddam BRD
 Director/Board Member 54 16-11-09
B V Ramakrishna AUD
 Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Venkata Ramana Gaddam BRD
 Director/Board Member 54 16-11-09
Satyanarayana Raju Bhupathiraju DFI
 Director of Finance/CFO 74 16-11-09
Alluri Ranga Raju BRD
 Director/Board Member 50 -
Hari Priya Yerukalapudi BRD
 Director/Board Member 33 22-07-28
Dilip Vishnu Acharekar CHM
 Chairman 61 20-11-15
Bhaskara Reddy Karna BRD
 Director/Board Member 45 20-11-15
Satish Pandurang Samant CEO
 Chief Executive Officer - 23-10-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,219,008 4,588,026 ( 49.77 %) 0 49.77 %

Company contact information

Vineet Laboratories Ltd.

5-5-160, Malleswari Nilayam Opposite Vishnu Theatre

500074, Hyderabad

+91 40 2412 8833

http://www.vineetlabs.co.in
address Vineet Laboratories Limited(VINEETLAB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
VINEET LABORATORIES LIMITED Stock Vineet Laboratories Limited
-28.05% 6.21M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.59% 727B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.89% 347B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.66% 319B
ABBVIE INC. Stock AbbVie Inc.
+0.24% 274B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.98% 238B
NOVARTIS AG Stock Novartis AG
+7.00% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-6.50% 203B
AMGEN INC. Stock Amgen Inc.
+4.23% 161B
PFIZER, INC. Stock Pfizer, Inc.
-1.70% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VINEETLAB Stock
  4. Company Vineet Laboratories Limited